BridgeBio Oncology Therapeutics, Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

BridgeBio Oncology Therapeutics, Inc. (BBOT) — Frequently Asked Questions

BridgeBio Oncology Therapeutics, Inc. (BBOT) is a publicly traded US company. Explore BBOT's stock price, financial statements, earnings history, margins and key ratios below.

What is the BBOT stock price?

BBOT trades at $7.37 (+3.44% on the day).